<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">Human bocavirus 1 (hBoV1) was first discovered in 2005 from patients with LRI in Sweden and was the first virus to be discovered by molecular virus screening [
 <xref ref-type="bibr" rid="CR52">52</xref>]. Since then, three additional species of HboV, hBoV2, hBoV3 and hBoV4 have been discovered, [
 <xref ref-type="bibr" rid="CR53">53</xref>–
 <xref ref-type="bibr" rid="CR55">55</xref>] although these species are found in the gastrointestinal tract and have been associated with gastroenteritis [
 <xref ref-type="bibr" rid="CR53">53</xref>–
 <xref ref-type="bibr" rid="CR55">55</xref>]. In contrast, HboV1 is associated with respiratory illness, and more specifically childhood ARI, with reported prevalence ranging from 1.5 to 19% [
 <xref ref-type="bibr" rid="CR56">56</xref>]. As with other respiratory viruses, diagnosis of hBoV1 infection is not possible by clinical presentation and for URI common symptoms include common cold-like symptoms and wheezing and for LRI clinical scenarios include pneumonia and bronchiolitis [
 <xref ref-type="bibr" rid="CR57">57</xref>].
</p>
